358 related articles for article (PubMed ID: 2119322)
1. Effects of non-esterified fatty acid availability on insulin stimulated glucose utilisation and tissue pyruvate dehydrogenase activity in the rat.
Kruszynska YT; McCormack JG; McIntyre N
Diabetologia; 1990 Jul; 33(7):396-402. PubMed ID: 2119322
[TBL] [Abstract][Full Text] [Related]
2. Effects of glycogen stores and non-esterified fatty acid availability on insulin-stimulated glucose metabolism and tissue pyruvate dehydrogenase activity in the rat.
Kruszynska YT; McCormack JG; McIntyre N
Diabetologia; 1991 Apr; 34(4):205-11. PubMed ID: 2065855
[TBL] [Abstract][Full Text] [Related]
3. Effect of nutritional status on insulin sensitivity in vivo and tissue enzyme activities in the rat.
Kruszynska YT; McCormack JG
Biochem J; 1989 Mar; 258(3):699-707. PubMed ID: 2499304
[TBL] [Abstract][Full Text] [Related]
4. Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man.
Ebeling P; Koivisto VA
Diabetologia; 1994 Feb; 37(2):202-9. PubMed ID: 8163056
[TBL] [Abstract][Full Text] [Related]
5. Lipid metabolism and insulin resistance in cirrhosis.
Kaye GL; Kruszynska YT; Harry DS; Heslop K; Johnston DG; McIntyre N
J Hepatol; 1994 Jun; 20(6):782-91. PubMed ID: 7930479
[TBL] [Abstract][Full Text] [Related]
6. Effects of FFA on insulin-stimulated glucose fluxes and muscle glycogen synthase activity in rats.
Park JY; Kim CH; Hong SK; Suh KI; Lee KU
Am J Physiol; 1998 Aug; 275(2):E338-44. PubMed ID: 9688637
[TBL] [Abstract][Full Text] [Related]
7. Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations.
Vaag AA; Handberg A; Skøtt P; Richter EA; Beck-Nielsen H
Eur J Endocrinol; 1994 Jan; 130(1):70-9. PubMed ID: 8124481
[TBL] [Abstract][Full Text] [Related]
8. Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man.
Johnson AB; Argyraki M; Thow JC; Cooper BG; Fulcher G; Taylor R
Clin Sci (Lond); 1992 Feb; 82(2):219-26. PubMed ID: 1311661
[TBL] [Abstract][Full Text] [Related]
9. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
Kim JK; Wi JK; Youn JH
Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
Oakes ND; Cooney GJ; Camilleri S; Chisholm DJ; Kraegen EW
Diabetes; 1997 Nov; 46(11):1768-74. PubMed ID: 9356024
[TBL] [Abstract][Full Text] [Related]
11. Contribution of muscle and liver to glucose-fatty acid cycle in humans.
Saloranta C; Koivisto V; Widén E; Falholt K; DeFronzo RA; Härkönen M; Groop L
Am J Physiol; 1993 Apr; 264(4 Pt 1):E599-605. PubMed ID: 8476039
[TBL] [Abstract][Full Text] [Related]
12. Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.
Burcelin R; Eddouks M; Maury J; Kande J; Assan R; Girard J
Diabetologia; 1995 Mar; 38(3):283-90. PubMed ID: 7758874
[TBL] [Abstract][Full Text] [Related]
13. Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats.
Guillaume-Gentil C; Assimacopoulos-Jeannet F; Jeanrenaud B
Diabetologia; 1993 Oct; 36(10):899-906. PubMed ID: 8243867
[TBL] [Abstract][Full Text] [Related]
14. Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo.
Jenkins AB; Storlien LH; Chisholm DJ; Kraegen EW
J Clin Invest; 1988 Jul; 82(1):293-9. PubMed ID: 3292587
[TBL] [Abstract][Full Text] [Related]
15. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW
Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study.
Jucker BM; Cline GW; Barucci N; Shulman GI
Diabetes; 1999 Jan; 48(1):134-40. PubMed ID: 9892234
[TBL] [Abstract][Full Text] [Related]
17. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
18. Intracellular defects in glucose metabolism in obese patients with NIDDM.
Kelley DE; Mokan M; Mandarino LJ
Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
[TBL] [Abstract][Full Text] [Related]
19. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
[TBL] [Abstract][Full Text] [Related]
20. Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion.
Cettour-Rose P; Theander-Carrillo C; Asensio C; Klein M; Visser TJ; Burger AG; Meier CA; Rohner-Jeanrenaud F
Diabetologia; 2005 Apr; 48(4):624-33. PubMed ID: 15756538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
